Old Web
English
Sign In
Acemap
>
authorDetail
>
Lin Po-Ting
Lin Po-Ting
Refractory period
Virology
Oncology
Hepatocellular carcinoma
Sorafenib
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
FRI-497-Shifting to sorafenib is beneficial for hepatocellular carcinoma patients with transarterial chemoembolization refractoriness: A real world experience
2019
Journal of Hepatology
Lin Po-Ting
RachelWen-Juei Jeng
Yi-Chung Hsieh
Wei Teng
Chen-Fu Hung
Chien-Hao Huang
Kar-Wai Lui
Yi-Cheng Chen
Chen Chun Lin
Chun-Yen Lin
Shi-Ming Lin
I-Shyan Sheen
Show All
Source
Cite
Save
Citations (0)
PM_2 5への曝露は胎児ラット脳皮質および海馬における遺伝的変化を引き起こす【Powered by NICT】
2017
Environmental Toxicology
Chao Ming-Wei
Yang Chin-Hua
Lin Po-Ting
Yang Yu-Hsiu
Chuang Yu-Chen
Chung Meng-Chi
Tseng Chia-Yi
Show All
Source
Cite
Save
Citations (0)
1